IONS Insider Cluster Buy: Director Hayden Adds $258K Stake
A fresh Form 4 filing shows Ionis Pharmaceuticals Inc (NASDAQ: IONS) director Michael R. Hayden purchased 5,000 shares of the company on the open market on July 31, 2026, paying $51.60 per share for a total outlay of $258,000. Following the purchase, Hayden’s stake stood at 24,000 shares, held indirectly through a trust or similar … Read more